Pharmaceutical Intermediates
Full official intermediate catalog + key intermediates with CEP / DMF / GMP / cold-chain qualifications and capacity details · each quotable via RFQ
Featured ProductsProven track record · documents on request
Enter hub →Dealt
Orforglipron intermediates
样品订单（各 500g）+ 0.5KG 复购
2 deals completed · latest 2026-09-21
Documents in progress
Dealt
PINACOLONE
两用物项贸易品类
2 deals completed · latest 2026-01-19
Documents in progress
Dealt
4-(3-Bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline
CAS 543737-10-6
1 deal completed · latest 2026-07-08
Documents in progress
By Therapeutic Area of Target Drug
Click a class to filter both sections below; classes follow the target API's primary indicationMetabolic / Endocrine62
Diabetes, obesity, dyslipidemia, NASH and other metabolic diseases
Cardiovascular / Renal58
Hypertension, heart failure, anticoagulation, chronic kidney disease
Oncology / Hematology193
Solid tumours, haematologic malignancies, myeloproliferative diseases
Anti-infectives17
Antiviral, antibacterial, antifungal, HIV / hepatitis
Immunology / Inflammation36
RA, psoriasis, atopic dermatitis, IBD
CNS / Psychiatry46
Epilepsy, pain, depression & anxiety, neurodegeneration
Gastroenterology / Hepatology28
Acid-related, GI motility, diarrhoea, liver disease
Respiratory11
COPD, asthma and other airway diseases
Urology / Women's Health35
Menopausal symptoms, urological conditions
Ophthalmology2
Glaucoma, ocular surface disease
Dermatology0
Skin infection, dermatologic inflammation
Anesthesia / Analgesia0
Local anaesthesia, postoperative analgesia
Allergy4
Allergic rhinitis, urticaria
Animal Health14
Companion-animal ectoparasiticides
Unclassified506
Qualified Key IntermediatesCEP / DMF / GMP / Cold-chain / Capacity / Price-band details
13 items| Product / CAS | Purity / Impurity profile (redacted) | Synthesis route (redacted) | Capacity | Qualifications | Packaging / Cold-chain | MOQ / Price band | Action |
|---|---|---|---|---|---|---|---|
Lenacapavir INT-1｜N-Boc 手性胺酯 CAS 1620056-47-4 · Antivirals Target drug: lenacapavir 高保密 | ≥99.0% 单杂 ≤0.10%，总杂 ≤0.50%（脱敏） | 手性还原 + Boc 保护（脱敏简述） | 1,200 kg/yr | US DMF | 5 kg / 25 kg 桶（铝箔袋内衬） | 1 kg US$ 2,600-3,800 / kg | Unibest Nantong cGMP Site |
Lenacapavir INT-2｜4-氯-7-硼酸酯吲唑 CAS 2189684-53-3 · Antivirals Target drug: lenacapavir 高保密 | ≥98.5% 有关物质谱见 CDA 资料室 | 吲唑构建 + Miyaura 硼化（脱敏简述） | 900 kg/yr | US DMF | 1 kg / 5 kg 铝瓶 Cold chain | 0.5 kg US$ 4,200-6,000 / kg | Unibest Nantong cGMP Site |
Lenacapavir INT-3｜环丙烷并环戊烷吡唑乙酸 CAS 1620056-83-8 · Antivirals Target drug: lenacapavir 高保密 | ≥99.0% 手性纯度 ≥99.5% ee（脱敏） | 双环构建 + 三氟甲基化（脱敏简述） | 700 kg/yr | US DMF | 1 kg 铝瓶 Cold chain | 0.5 kg US$ 5,800-8,200 / kg | Unibest Nantong cGMP Site |
Lenacapavir INT-4｜3-甲基-3-(甲磺酰基)-1-丁炔 CAS 2109226-54-0 · Antivirals Target drug: lenacapavir CDA 后可看 | ≥98.0% 单杂 ≤0.20%（脱敏） | 炔基化 + 砜基引入（脱敏简述） | 2,400 kg/yr | 25 kg 桶 | 5 kg US$ 780-1,150 / kg | Unibest Taizhou GMP-like Site | |
Lenacapavir (GS-6207) API CAS 2189684-44-2 · Antivirals Target drug: lenacapavir 高保密 | ≥99.5% 单杂 ≤0.10%，总杂 ≤0.30%（脱敏） | 汇聚式偶联 + 成盐（脱敏简述） | 300 kg/yr | US DMFEU GMP | 100 g / 1 kg 铝瓶（密闭系统） Cold chain | 100 g 🔒 CDA 后开放 | Unibest Nantong cGMP Site |
Doravirine INT-1｜3-氯-5-[(吡啶基)氧基]苯甲腈 CAS 1155846-86-8 · Antivirals Target drug: doravirine CDA 后可看 | ≥99.0% 单杂 ≤0.15%（脱敏） | 芳香亲核取代成醚（脱敏简述） | 3,600 kg/yr | US DMFEU GMP | 25 kg 桶 | 10 kg US$ 420-620 / kg | Qualified Partner — East China API Works |
Doravirine INT-2｜3-氯-5-碘苯酚 CAS 861347-86-6 · Antivirals Target drug: doravirine | ≥99.0% 单杂 ≤0.15%（脱敏） | 选择性碘代（脱敏简述） | 5,200 kg/yr | 25 kg 桶 | 25 kg US$ 210-320 / kg | Qualified Partner — East China API Works | |
Entecavir INT-1｜嘌呤核苷中间体 CAS 142217-80-9 · Antivirals Target drug: entecavir | ≥99.0% 单杂 ≤0.10%（脱敏） | 糖苷化 + 保护基策略（脱敏简述） | 1,800 kg/yr | CEPUS DMFEU GMP | 5 kg / 25 kg 桶 | 5 kg US$ 1,150-1,700 / kg | Qualified Partner — East China API Works |
Belzutifan INT-1｜(R)-3-氟-5-[(茚满酮基)氧基]苯甲腈 CAS 2738675-96-0 · Anti-cancer Target drug: belzutifan 高保密 | ≥99.0% 手性纯度 ≥99.5% ee（脱敏） | 手性还原 + 成醚（脱敏简述） | 800 kg/yr | US DMF | 1 kg / 5 kg 铝瓶 | 1 kg US$ 3,400-4,900 / kg | Unibest Taizhou GMP-like Site |
Belzutifan INT-2｜3-[(茚满酮基)氧基]-5-氟苯甲腈 CAS 1672665-55-2 · Anti-cancer Target drug: belzutifan 高保密 | ≥99.0% 单杂 ≤0.10%（脱敏） | 成醚 + 砜基氧化（脱敏简述） | 1,100 kg/yr | 5 kg 桶 | 2 kg US$ 2,100-3,100 / kg | Unibest Taizhou GMP-like Site | |
2'-dG(iBu) 亚磷酰胺单体 CAS 68892-42-2 · Nucleic Acids Target drug: oligonucleotide | ≥99.0% 单杂 ≤0.10%（脱敏） | 核苷保护 + 亚磷酰化（脱敏简述） | 400 kg/yr | US DMFEU GMP | 100 g / 1 kg 铝瓶 Cold chain | 100 g US$ 1,600-2,400 / 100g | Unibest Nantong cGMP Site |
2'-dA(Bz) 亚磷酰胺单体 CAS 4546-72-9 · Nucleic Acids Target drug: oligonucleotide | ≥99.0% 单杂 ≤0.10%（脱敏） | 核苷保护 + 亚磷酰化（脱敏简述） | 400 kg/yr | US DMFEU GMP | 100 g / 1 kg 铝瓶 Cold chain | 100 g US$ 1,480-2,200 / 100g | Unibest Nantong cGMP Site |
2'-dC(Bz) 亚磷酰胺单体 CAS 4836-13-9 · Nucleic Acids Target drug: oligonucleotide | ≥99.0% 单杂 ≤0.10%（脱敏） | 核苷保护 + 亚磷酰化（脱敏简述） | 350 kg/yr | US DMFEU GMP | 100 g / 1 kg 铝瓶 Cold chain | 100 g US$ 1,520-2,280 / 100g | Unibest Nantong cGMP Site |
Official Intermediate Full CatalogWith CAS numbers · Aggregated by target drug
Total 493 intermediates · covering 255 target drugs| Intermediate name | CAS No. | Target drug | Action |
|---|---|---|---|
| 5-piperazin-1-yl-1-benzofuran-2-carboxamide | 183288-46-2 | Vilazodone Hydrochloride | |
| (2-Chloro-3-pyridinyl)methanol | 42330-59-6 | Voxelotor | |
| 1-Isopropyl-1H-pyrazole-5-boronic acid, pinacol ester | 1282518-60-8 | Voxelotor | |
| 2-hydroxy-6-(methoxymethoxy)benzaldehyde | 84290-49-3 | Voxelotor | |
| 3-(chloromethyl)-2-(1-isopropyl-1H-pyrazol-5-yl)pyridine hydrochloride | 1446321-95-4 | Voxelotor | |
| 3-Chloro-4-(pyridin-3-yl)-1,2,5-thiadiazole | 131986-28-2 | Xanomeline | |
| 2-PYRIDINECARBOXYLIC ACID, 3-CHLORO-5-(TRIFLUOROMETHYL)-, ETHYL ESTER | 128073-16-5 | Zelicapavir | |
| (S)-2-((tert-butoxycarbonyl)amino)pent-4-enoic acid | 90600-20-7 | Zipalertinib | |
| (S)-Methyl-2-Boc-AMino-4-pentenoic acid | 89985-87-5 | Zipalertinib | |
| L-allylglycine | 16338-48-0 | Zipalertinib | |
| tert-butyl (S)-(1-(4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)pent-4-en-2-yl)carbamate | 1451370-49-2 | Zipalertinib | |
| 6-Chloro-5-(2-chloroethyl)oxindole | 118289-55-7 | Ziprasidone Hydrochloride | |
| 6-Chlorooxindole | 56341.37-8 | Ziprasidone Hydrochloride |
‹ PrevPage 9 / 9